Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ciprofloxacin therapy for Mediterranean spotted fever.

Literature DB >> 3789693

Ciprofloxacin therapy for Mediterranean spotted fever.

D Raoult, H Gallais, P De Micco, P Casanova.

Abstract

We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.

Entities: Chemical Disease Species

Mesh：

Substances：
Ciprofloxacin

Year: 1986 PMID： 3789693 PMCID： PMC176489 DOI： 10.1128/AAC.30.4.606

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

5 in total

1. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay.

Authors: D Raoult; P Roussellier; V Galicher; R Perez; J Tamalet
Journal: Antimicrob Agents Chemother Date: 1986-03 Impact factor: 5.191

2. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases.

Authors: D Raoult; P J Weiller; A Chagnon; H Chaudet; H Gallais; P Casanova
Journal: Am J Trop Med Hyg Date: 1986-07 Impact factor: 2.345

Review 3. Mediterranean spotted fever: a cooperative study of 227 cases.

Authors: B Font-Creus; F Bella-Cueto; E Espejo-Arenas; R Vidal-Sanahuja; T Muñoz-Espin; M Nolla-Salas; A Casagran-Borrell; J Mercade-Cuesta; F Segura-Porta
Journal: Rev Infect Dis Date: 1985 Sep-Oct

4. [Malignant form of Mediterranean boutonneuse fever. 6 cases].

Authors: D Raoult; H Gallais; A Ottomani; J P Resch; D Tichadou; P De Micco; P Casanova
Journal: Presse Med Date: 1983-10-29 Impact factor: 1.228

5. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors: G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal: Antimicrob Agents Chemother Date: 1985-03 Impact factor: 5.191

5 in total

19 in total

1. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever.

Authors: R Ruiz Beltrán; J I Herrero Herrero
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-05 Impact factor: 3.267

2. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.

Authors: F Gudiol; R Pallares; J Carratala; F Bolao; J Ariza; G Rufi; P F Viladrich
Journal: Antimicrob Agents Chemother Date: 1989-06 Impact factor: 5.191

3. Chloramphenicol, gentamicin, and ciprofloxacin against murine scrub typhus.

Authors: J B McClain; B Joshi; R Rice
Journal: Antimicrob Agents Chemother Date: 1988-02 Impact factor: 5.191

Review 4. Antimicrobial therapy of rickettsial diseases.

Authors: D Raoult; M Drancourt
Journal: Antimicrob Agents Chemother Date: 1991-12 Impact factor: 5.191

Review 5. Optimum treatment of intracellular infection.

Authors: M Maurin; D Raoult
Journal: Drugs Date: 1996-07 Impact factor: 9.546

6. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors: E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

7. Susceptibility of Rickettsia rickettsii to Tigecycline in a Cell Culture Assay and Animal Model for Rocky Mountain Spotted Fever.

Authors: Lucas S Blanton; Nicholas M Wilson; Bethany R Quade; David H Walker
Journal: Am J Trop Med Hyg Date: 2019-11 Impact factor: 2.345

8. Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.

Authors: N Jabarit-Aldighieri; H Torres; D Raoult
Journal: Antimicrob Agents Chemother Date: 1992-11 Impact factor: 5.191

Review 9. Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors: D Raoult
Journal: Eur J Epidemiol Date: 1991-05 Impact factor: 8.082

10. In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin.

Authors: D Raoult; P Bres; M Drancourt; G Vestris
Journal: Antimicrob Agents Chemother Date: 1991-01 Impact factor: 5.191